Human Genetics of Ebstein Anomaly


Chromosomal disorder

Number of patients reported

Proven or suspected causal gene(s)

References

Deletion 1p36

9

DVL1, SKI, RERE, PDPN, SPEN, CLCNKA, ECE1, HSPG2, LUZP1, WASF2, PRDM16, PRKCZ, UBE4B, MASP2

[12, 3444]

Microdeletion 5q35

2

NKX2-5

[44, 45]

Deletion 8p23.1

3

GATA4

[12, 46, 47]

Duplication 9p

2

Unknown

[48, 49]

Deletion and duplication 11q

1

ETS1

[50]

Duplication 15q

2

Unknown

[51, 52]

Trisomy 18

1

Unknown

[1]

Deletion 18q21.3- > qter

3

NFATC1

[12, 53]

Trisomy 21

8

Unknown

[5461]



Syndromic forms of congenital heart disease also can be caused by single genes or be of unknown genetic origin. In a larger case series with 44 patients with Ebstein anomaly, 12 (27 %) had syndromic presentation, and 7 of those had distinct disorders including CHARGE syndrome (N = 2), VACTERL association, Noonan syndrome, Kabuki syndrome, Holt-Oram syndrome, and Cornelia de Lange syndrome (one each) [12]. An additional two patients with CHARGE syndrome have been reported in the literature, both of which carry mutations in CHD7 (chromodomain helicase DNA binding protein 7), as well as one additional patient each with Kabuki syndrome, Holt-Oram syndrome, Noonan syndrome, Williams syndrome, and Ellis-van Creveld syndrome without mutation screening [6267]. A single patient with thiamine-responsive megaloblastic anemia and Ebstein anomaly has been reported; interestingly, several other cardiac defects have been described in this syndrome, including one case of atrial standstill, which can be part of Ebstein syndrome [6870]. A relatively high number of patients with Ebstein anomaly and Down syndrome have been reported in the literature (Table 53.1); however, one has to keep in mind that the denominator of all children born with trisomy 21 is much higher than for all other chromosomal imbalances listed here.


Conclusion

Clinical, epidemiological, and molecular evidence supports the hypothesis that Ebstein anomaly has strong genetic determinants. While the genetic causes are heterogenous, overlapping phenotypes are observed even in genetically distinct entities. Prime examples for these phenomena are left ventricular noncompaction in both MYH7 mutation and 1p36 deletion carriers or the spectrum of recurring right-sided malformations in patients with Ebstein anomaly and 18q21 deletion. Genes contributing to Ebstein anomaly affect diverse developmental pathways, with variable expressivity and incomplete penetrance being common observations in multiplex families. It is very likely that the causal genes identified to date act in concert with modifiers, either environmental or (epi)genetic. The most frequent chromosomal imbalances contributing to Ebstein anomaly are the microdeletions 1p36 and 8p23.1. It can be anticipated that use of molecular karyotyping and next-generation sequencing technologies will increase the gene catalogue involved in the pathogenesis of Ebstein anomaly.



Acknowledgments

GA is funded by the Fonds de Recherche en Santé du Québec, the Canadian Institutes of Health Research, Nussia and André Aisenstadt Foundation, Fondation GO, and Fondation Leducq. He holds the Banque Nationale Research Chair in Cardiovascular Genetics.


References



1.

Correa-Villasenor A, Ferencz C, Neill CA et al (1994) Ebstein’s malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group. Teratology 50:137–147PubMedCrossRef


2.

Emanuel R, O’Brien K, Ng R (1976) Ebstein’s anomaly. Genetic study of 26 families. Br Heart J 38:5–7PubMedCentralPubMedCrossRef


3.

Lo KS, Loventhal JP, Walton JA Jr (1979) Familial Ebstein’s anomaly. Cardiology 64:246–255PubMedCrossRef


4.

McIntosh N, Chitayat D, Bardanis M et al (1992) Ebstein anomaly: report of a familial occurrence and prenatal diagnosis. Am J Med Genet 42:307–309PubMedCrossRef


5.

Gueron M, Hirsch M, Stern J et al (1966) Familial Ebstein’s anomaly with emphasis on the surgical treatment. Am J Cardiol 18:105–111PubMedCrossRef


6.

Uyan C, Yazici M, Uyan AP et al (2002) Ebstein’s anomaly in siblings: an original observation. Int J Cardiovasc Imaging 18:435–438PubMedCrossRef


7.

Balaji S, Dennis NR, Keeton BR (1991) Familial Ebstein’s anomaly: a report of six cases in two generations associated with mild skeletal abnormalities. Br Heart J 66:26–28PubMedCentralPubMedCrossRef


8.

Megarbane A, Stephan E, Kassab R et al (1999) Autosomal dominant secundum atrial septal defect with various cardiac and noncardiac defects: a new midline disorder. Am J Med Genet 83:193–200PubMedPubMedCrossRef


10.

Grant JW (1996) Congenital malformations of the tricuspid valve in siblings. Pediatr Cardiol 17:327–329PubMedCrossRef


11.

Benson DW, Silberbach GM, Kavanaugh-McHugh A et al (1999) Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 104:1567–1573PubMedCentralPubMedCrossRef


12.

Digilio MC, Bernardini L, Lepri F et al (2011) Ebstein anomaly: genetic heterogeneity and association with microdeletions 1p36 and 8p23.1. Am J Med Genet A 155A:2196–2202PubMedCrossRef


13.

Delhaas T, Sarvaas GJ, Rijlaarsdam ME et al (2010) A multicenter, long-term study on arrhythmias in children with Ebstein anomaly. Pediatr Cardiol 31:229–233PubMedCentralPubMedCrossRef


14.

Andelfinger G, Wright KN, Lee HS et al (2003) Canine tricuspid valve malformation, a model of human Ebstein anomaly, maps to dog chromosome 9. J Med Genet 40:320–324PubMedCentralPubMedCrossRef


15.

Werner P, Raducha MG, Prociuk U et al (2005) The keeshond defect in cardiac conotruncal development is oligogenic. Hum Genet 116:368–377PubMedCrossRef

Nov 21, 2016 | Posted by in CARDIOLOGY | Comments Off on Human Genetics of Ebstein Anomaly

Full access? Get Clinical Tree

Get Clinical Tree app for offline access